ViaNautis
ViaNautis has developed PolyNaut®, a versatile nano-engineered polymer technology designed for targeted intracellular delivery
ViaNautis has raised €23M across 1 funding round from 8 investors, most recently a Series A round in Nov 2023. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKvianautis.com ↗
Total raised
€23M
€22,947,622
Funding rounds
1
Investors
8
distinct backers
Active since
2023-11
latest 2023-11
Funding by year
EUR raised per yearViaNautis — funding by year — interactive chart.
Data table
| ViaNautis — funding by year | |
|---|---|
| 2023 | €23M |
Signals
High confidenceRaise-next likelihood14
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-11-13 | Series A | €23M | 4BIO Capital,BGF,Cystic Fibrosis Foundation,Eli lilly and company,Meltwind,o2h Ventures+2 more | View deal → |